HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PRODUCTIVE INFECTION IN STAUROSPORINE-BLOCKED QUIESCENT CELLS

被引:2
|
作者
ARANDAANZALDO, A
VIZA, D
机构
[1] URA-CNRS, Laboratoire d'Immumobiologie, Facultè de Mèdecine, 75006 Paris, 45, rue des Saints-Pères
关键词
PROTEIN KINASE INHIBITOR; VIRAL INFECTIVITY; CELL CYCLE; T-CELL;
D O I
10.1016/0014-5793(92)81268-Q
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Staurosporine, an antibiotic known to inhibit cellular protein kinases, can reversibly block the progress of normal and tumour cells into the cell cycle. The ability of HIV-1 to infect and replicate in cells blocked by staurosporine was investigated. The results show that blocked, non-cycling cells can be productively infected by HIV-1, steadily releasing infectious progeny virus for several weeks. This suggests that at least in some cases. HIV-1 can be found in a stable and active state in resting, non-proliferating T cells.
引用
收藏
页码:170 / 174
页数:5
相关论文
共 50 条
  • [21] IN-VITRO INFECTION OF EPIDERMAL LANGERHANS CELLS WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    GIROLOMONI, G
    ZAMBRUNO, G
    RE, MC
    RAMAZZOTTI, E
    MARCONI, A
    FURLINI, G
    VIGNOLI, M
    GIANNETTI, A
    LAPLACA, M
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 102 (04) : 543 - 543
  • [22] MORPHOLOGY AND PHENOTYPE OF DENDRITIC CELLS FROM PERIPHERAL-BLOOD AND THEIR PRODUCTIVE AND NONPRODUCTIVE INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    PATTERSON, S
    GROSS, J
    BEDFORD, P
    KNIGHT, SC
    IMMUNOLOGY, 1991, 72 (03) : 361 - 367
  • [23] ANAPLASTIC ASTROCYTOMA IN ASSOCIATION WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    CARRANA, EJ
    ROSSITCH, E
    MOORE, MR
    FUNKENSTEIN, HH
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 1990, 8 (06): : 565 - 567
  • [24] PSYCHONEUROIMMUNOLOGY AND HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION REVISITED - REPLY
    PERRY, S
    RABKIN, J
    ARCHIVES OF GENERAL PSYCHIATRY, 1994, 51 (03) : 247 - 248
  • [25] LABORATORY TESTS FOR DETECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    NUWAYHID, NF
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1995, 2 (06) : 637 - 645
  • [26] INFECTION BY THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN THE PRISON POPULATION IN CATALONIA
    BAYAS, JM
    MARTIN, V
    VIDAL, J
    PUMAROLA, T
    DEANTA, MTJ
    SALLERAS, L
    MEDICINA CLINICA, 1994, 102 (06): : 209 - 212
  • [27] MORPHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CHATTERJEE, S
    BASAK, S
    KHAN, NC
    PATHOBIOLOGY, 1992, 60 (04) : 181 - 186
  • [28] INHIBITION OF INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY SULFATED GANGLIOSIDES
    HANDA, A
    HOSHINO, H
    NAKAJIMA, K
    ADACHI, M
    IKEDA, K
    ACHIWA, K
    ITOH, T
    SUZUKI, Y
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 175 (01) : 1 - 9
  • [29] TREATMENT TRIALS FOR PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    NIU, MT
    STEIN, DS
    SCHNITTMAN, SM
    JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (06): : 1601 - 1602
  • [30] INFECTION OF MACACA-NEMESTRINA BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    AGY, MB
    FRUMKIN, LR
    COREY, L
    COOMBS, RW
    WOLINSKY, SM
    KOEHLER, J
    MORTON, WR
    KATZE, MG
    SCIENCE, 1992, 257 (5066) : 103 - 106